nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—PLA2G1B—atherosclerosis	0.225	0.51	CbGaD
Sulfasalazine—SLC7A11—Rosuvastatin—atherosclerosis	0.137	0.335	CbGbCtD
Sulfasalazine—ALOX5—atherosclerosis	0.12	0.27	CbGaD
Sulfasalazine—PPARG—atherosclerosis	0.0684	0.155	CbGaD
Sulfasalazine—PTGS2—atherosclerosis	0.0289	0.0653	CbGaD
Sulfasalazine—SLCO1B1—Ezetimibe—atherosclerosis	0.0227	0.0554	CbGbCtD
Sulfasalazine—SLCO1B1—Rosuvastatin—atherosclerosis	0.0227	0.0554	CbGbCtD
Sulfasalazine—SLCO1B1—Simvastatin—atherosclerosis	0.0211	0.0515	CbGbCtD
Sulfasalazine—SLCO1B1—Pravastatin—atherosclerosis	0.0206	0.0504	CbGbCtD
Sulfasalazine—SLCO1B1—Lovastatin—atherosclerosis	0.0206	0.0504	CbGbCtD
Sulfasalazine—ABCC2—Ezetimibe—atherosclerosis	0.0199	0.0487	CbGbCtD
Sulfasalazine—ABCC2—Simvastatin—atherosclerosis	0.0185	0.0452	CbGbCtD
Sulfasalazine—ABCC2—Lovastatin—atherosclerosis	0.0181	0.0443	CbGbCtD
Sulfasalazine—ABCC2—Pravastatin—atherosclerosis	0.0181	0.0443	CbGbCtD
Sulfasalazine—ABCG2—Rosuvastatin—atherosclerosis	0.018	0.044	CbGbCtD
Sulfasalazine—ABCG2—Ezetimibe—atherosclerosis	0.018	0.044	CbGbCtD
Sulfasalazine—ABCG2—Pravastatin—atherosclerosis	0.0164	0.04	CbGbCtD
Sulfasalazine—CYP3A5—Rosuvastatin—atherosclerosis	0.00998	0.0244	CbGbCtD
Sulfasalazine—CYP3A5—Simvastatin—atherosclerosis	0.00928	0.0227	CbGbCtD
Sulfasalazine—CYP3A5—Lovastatin—atherosclerosis	0.00908	0.0222	CbGbCtD
Sulfasalazine—CYP3A5—Pravastatin—atherosclerosis	0.00908	0.0222	CbGbCtD
Sulfasalazine—TBXAS1—leg—atherosclerosis	0.00464	0.101	CbGeAlD
Sulfasalazine—TBXAS1—hindlimb—atherosclerosis	0.00414	0.0906	CbGeAlD
Sulfasalazine—TBXAS1—appendage—atherosclerosis	0.00355	0.0777	CbGeAlD
Sulfasalazine—PPARG—leg—atherosclerosis	0.00175	0.0382	CbGeAlD
Sulfasalazine—PLA2G1B—blood vessel—atherosclerosis	0.00166	0.0363	CbGeAlD
Sulfasalazine—PPARG—hindlimb—atherosclerosis	0.00156	0.0342	CbGeAlD
Sulfasalazine—PPARG—appendage—atherosclerosis	0.00134	0.0293	CbGeAlD
Sulfasalazine—ACAT1—connective tissue—atherosclerosis	0.00121	0.0265	CbGeAlD
Sulfasalazine—ACAT1—cardiovascular system—atherosclerosis	0.00105	0.0231	CbGeAlD
Sulfasalazine—TBXAS1—connective tissue—atherosclerosis	0.00101	0.0222	CbGeAlD
Sulfasalazine—PPARG—artery—atherosclerosis	0.000957	0.0209	CbGeAlD
Sulfasalazine—ACAT1—adipose tissue—atherosclerosis	0.00093	0.0204	CbGeAlD
Sulfasalazine—CHUK—connective tissue—atherosclerosis	0.000903	0.0198	CbGeAlD
Sulfasalazine—PTGS2—leg—atherosclerosis	0.000893	0.0195	CbGeAlD
Sulfasalazine—TBXAS1—cardiovascular system—atherosclerosis	0.000882	0.0193	CbGeAlD
Sulfasalazine—PLA2G1B—connective tissue—atherosclerosis	0.000849	0.0186	CbGeAlD
Sulfasalazine—PPARG—endothelium—atherosclerosis	0.000808	0.0177	CbGeAlD
Sulfasalazine—PTGS2—hindlimb—atherosclerosis	0.000797	0.0175	CbGeAlD
Sulfasalazine—CHUK—cardiovascular system—atherosclerosis	0.000786	0.0172	CbGeAlD
Sulfasalazine—TBXAS1—adipose tissue—atherosclerosis	0.000778	0.017	CbGeAlD
Sulfasalazine—PPARG—blood vessel—atherosclerosis	0.000745	0.0163	CbGeAlD
Sulfasalazine—PLA2G1B—cardiovascular system—atherosclerosis	0.000739	0.0162	CbGeAlD
Sulfasalazine—Olsalazine—IFNG—atherosclerosis	0.000722	0.227	CrCbGaD
Sulfasalazine—Balsalazide—ALOX5—atherosclerosis	0.000699	0.22	CrCbGaD
Sulfasalazine—CHUK—adipose tissue—atherosclerosis	0.000693	0.0152	CbGeAlD
Sulfasalazine—PTGS2—appendage—atherosclerosis	0.000684	0.015	CbGeAlD
Sulfasalazine—ACAT1—liver—atherosclerosis	0.000652	0.0143	CbGeAlD
Sulfasalazine—IKBKB—connective tissue—atherosclerosis	0.000614	0.0134	CbGeAlD
Sulfasalazine—Olsalazine—ALOX5—atherosclerosis	0.000594	0.187	CrCbGaD
Sulfasalazine—SLC7A11—adipose tissue—atherosclerosis	0.000571	0.0125	CbGeAlD
Sulfasalazine—TBXAS1—liver—atherosclerosis	0.000545	0.0119	CbGeAlD
Sulfasalazine—IKBKB—cardiovascular system—atherosclerosis	0.000534	0.0117	CbGeAlD
Sulfasalazine—PTGS1—artery—atherosclerosis	0.000511	0.0112	CbGeAlD
Sulfasalazine—ALOX5—connective tissue—atherosclerosis	0.000509	0.0111	CbGeAlD
Sulfasalazine—PTGS2—artery—atherosclerosis	0.000489	0.0107	CbGeAlD
Sulfasalazine—SLC46A1—liver—atherosclerosis	0.000486	0.0106	CbGeAlD
Sulfasalazine—CHUK—liver—atherosclerosis	0.000486	0.0106	CbGeAlD
Sulfasalazine—IKBKB—adipose tissue—atherosclerosis	0.000471	0.0103	CbGeAlD
Sulfasalazine—ALOX5—cardiovascular system—atherosclerosis	0.000443	0.00969	CbGeAlD
Sulfasalazine—PTGS1—endothelium—atherosclerosis	0.000432	0.00946	CbGeAlD
Sulfasalazine—PTGS2—endothelium—atherosclerosis	0.000413	0.00904	CbGeAlD
Sulfasalazine—Balsalazide—PPARG—atherosclerosis	0.0004	0.126	CrCbGaD
Sulfasalazine—PTGS1—blood vessel—atherosclerosis	0.000398	0.00872	CbGeAlD
Sulfasalazine—ALOX5—adipose tissue—atherosclerosis	0.00039	0.00855	CbGeAlD
Sulfasalazine—PPARG—connective tissue—atherosclerosis	0.000382	0.00836	CbGeAlD
Sulfasalazine—PTGS2—blood vessel—atherosclerosis	0.000381	0.00833	CbGeAlD
Sulfasalazine—Olsalazine—PPARG—atherosclerosis	0.00034	0.107	CrCbGaD
Sulfasalazine—PPARG—cardiovascular system—atherosclerosis	0.000332	0.00728	CbGeAlD
Sulfasalazine—IKBKB—liver—atherosclerosis	0.00033	0.00723	CbGeAlD
Sulfasalazine—PPARG—adipose tissue—atherosclerosis	0.000293	0.00642	CbGeAlD
Sulfasalazine—ALOX5—liver—atherosclerosis	0.000274	0.00599	CbGeAlD
Sulfasalazine—SLCO1B1—liver—atherosclerosis	0.000238	0.00522	CbGeAlD
Sulfasalazine—PPARG—liver—atherosclerosis	0.000206	0.0045	CbGeAlD
Sulfasalazine—PTGS1—connective tissue—atherosclerosis	0.000204	0.00447	CbGeAlD
Sulfasalazine—PTGS2—connective tissue—atherosclerosis	0.000195	0.00427	CbGeAlD
Sulfasalazine—ABCG2—adipose tissue—atherosclerosis	0.000188	0.00411	CbGeAlD
Sulfasalazine—ABCC2—liver—atherosclerosis	0.000181	0.00396	CbGeAlD
Sulfasalazine—PTGS1—cardiovascular system—atherosclerosis	0.000178	0.00389	CbGeAlD
Sulfasalazine—CYP3A5—adipose tissue—atherosclerosis	0.000174	0.00382	CbGeAlD
Sulfasalazine—PTGS2—cardiovascular system—atherosclerosis	0.00017	0.00372	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—atherosclerosis	0.000169	0.0531	CrCbGaD
Sulfasalazine—PTGS1—adipose tissue—atherosclerosis	0.000157	0.00343	CbGeAlD
Sulfasalazine—PTGS2—adipose tissue—atherosclerosis	0.00015	0.00328	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—atherosclerosis	0.000144	0.0451	CrCbGaD
Sulfasalazine—ABCG2—liver—atherosclerosis	0.000132	0.00288	CbGeAlD
Sulfasalazine—CYP3A5—liver—atherosclerosis	0.000122	0.00268	CbGeAlD
Sulfasalazine—Vismodegib—ALB—atherosclerosis	0.000112	0.0353	CrCbGaD
Sulfasalazine—PTGS2—liver—atherosclerosis	0.000105	0.0023	CbGeAlD
Sulfasalazine—PTGS2—Metabolism—LDLR—atherosclerosis	3.66e-06	3.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ABCA1—atherosclerosis	3.63e-06	3.65e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MAPK3—atherosclerosis	3.63e-06	3.65e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PPARA—atherosclerosis	3.59e-06	3.61e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SOCS3—atherosclerosis	3.58e-06	3.6e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CETP—atherosclerosis	3.58e-06	3.59e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS2—atherosclerosis	3.56e-06	3.58e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KNG1—atherosclerosis	3.54e-06	3.56e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ICAM1—atherosclerosis	3.52e-06	3.54e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AGTR1—atherosclerosis	3.52e-06	3.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.51e-06	3.53e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NAMPT—atherosclerosis	3.5e-06	3.52e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—HMOX1—atherosclerosis	3.5e-06	3.52e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—LIPC—atherosclerosis	3.48e-06	3.5e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AGT—atherosclerosis	3.48e-06	3.5e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOC3—atherosclerosis	3.46e-06	3.48e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP3—atherosclerosis	3.46e-06	3.48e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF2—atherosclerosis	3.44e-06	3.46e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—SERPINE1—atherosclerosis	3.44e-06	3.46e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—LDLR—atherosclerosis	3.44e-06	3.46e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PLG—atherosclerosis	3.43e-06	3.45e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—SCARB1—atherosclerosis	3.42e-06	3.44e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—APOE—atherosclerosis	3.41e-06	3.43e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CAV1—atherosclerosis	3.38e-06	3.39e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—APOA1—atherosclerosis	3.37e-06	3.39e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CETP—atherosclerosis	3.36e-06	3.38e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOB—atherosclerosis	3.35e-06	3.37e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOB—atherosclerosis	3.34e-06	3.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.33e-06	3.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EDN1—atherosclerosis	3.29e-06	3.31e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MAPK3—atherosclerosis	3.29e-06	3.31e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL5—atherosclerosis	3.26e-06	3.28e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—INS—atherosclerosis	3.26e-06	3.28e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GSTM1—atherosclerosis	3.26e-06	3.28e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SOCS3—atherosclerosis	3.25e-06	3.26e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—HMOX1—atherosclerosis	3.24e-06	3.26e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HMGCR—atherosclerosis	3.23e-06	3.25e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—SCARB1—atherosclerosis	3.22e-06	3.23e-05	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—AKT1—atherosclerosis	3.21e-06	3.22e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—LPL—atherosclerosis	3.2e-06	3.22e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—IL6—atherosclerosis	3.2e-06	3.21e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—LPL—atherosclerosis	3.19e-06	3.21e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP3—atherosclerosis	3.14e-06	3.15e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GPX1—atherosclerosis	3.12e-06	3.14e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF2—atherosclerosis	3.12e-06	3.14e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—HMOX1—atherosclerosis	3.11e-06	3.13e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOB—atherosclerosis	3.11e-06	3.12e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PRKCG—atherosclerosis	3.1e-06	3.12e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CG—atherosclerosis	3.08e-06	3.09e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CD36—atherosclerosis	3.04e-06	3.06e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HMGCR—atherosclerosis	3.04e-06	3.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOB—atherosclerosis	3.03e-06	3.05e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SPP1—atherosclerosis	3.02e-06	3.04e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSTM1—atherosclerosis	3.02e-06	3.04e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SERPINE1—atherosclerosis	3e-06	3.01e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOB—atherosclerosis	2.98e-06	3e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EDN1—atherosclerosis	2.98e-06	3e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—LPL—atherosclerosis	2.96e-06	2.98e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL5—atherosclerosis	2.96e-06	2.97e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNG—atherosclerosis	2.96e-06	2.97e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—atherosclerosis	2.95e-06	2.97e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—INS—atherosclerosis	2.91e-06	2.93e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTM1—atherosclerosis	2.9e-06	2.92e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LPL—atherosclerosis	2.89e-06	2.91e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GPX1—atherosclerosis	2.89e-06	2.91e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—MTHFR—atherosclerosis	2.88e-06	2.9e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCA1—atherosclerosis	2.88e-06	2.9e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS3—atherosclerosis	2.86e-06	2.88e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—LPL—atherosclerosis	2.85e-06	2.86e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PPARA—atherosclerosis	2.83e-06	2.84e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOB—atherosclerosis	2.83e-06	2.84e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CD36—atherosclerosis	2.82e-06	2.83e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PRKCG—atherosclerosis	2.81e-06	2.83e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PDGFB—atherosclerosis	2.8e-06	2.81e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GPX1—atherosclerosis	2.78e-06	2.79e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SPP1—atherosclerosis	2.74e-06	2.75e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AGT—atherosclerosis	2.74e-06	2.75e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AGT—atherosclerosis	2.73e-06	2.74e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCA1—atherosclerosis	2.71e-06	2.72e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CD36—atherosclerosis	2.71e-06	2.72e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—LPL—atherosclerosis	2.7e-06	2.71e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOE—atherosclerosis	2.68e-06	2.7e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNG—atherosclerosis	2.68e-06	2.7e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—LEP—atherosclerosis	2.68e-06	2.69e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOE—atherosclerosis	2.68e-06	2.69e-05	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—atherosclerosis	2.68e-06	2.69e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ALB—atherosclerosis	2.67e-06	2.68e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—MTHFR—atherosclerosis	2.67e-06	2.68e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CAV1—atherosclerosis	2.66e-06	2.67e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOA1—atherosclerosis	2.65e-06	2.67e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—atherosclerosis	2.65e-06	2.67e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CAV1—atherosclerosis	2.65e-06	2.66e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOA1—atherosclerosis	2.65e-06	2.66e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1B—atherosclerosis	2.64e-06	2.65e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PRKCG—atherosclerosis	2.63e-06	2.64e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPARA—atherosclerosis	2.62e-06	2.63e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—atherosclerosis	2.62e-06	2.63e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—MTHFR—atherosclerosis	2.56e-06	2.58e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ESR1—atherosclerosis	2.55e-06	2.57e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NOS3—atherosclerosis	2.55e-06	2.57e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PDGFB—atherosclerosis	2.54e-06	2.55e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AGT—atherosclerosis	2.54e-06	2.55e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—F2—atherosclerosis	2.52e-06	2.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPARA—atherosclerosis	2.52e-06	2.53e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOE—atherosclerosis	2.49e-06	2.5e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AGT—atherosclerosis	2.48e-06	2.49e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HMOX1—atherosclerosis	2.47e-06	2.48e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CAV1—atherosclerosis	2.46e-06	2.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NFKB1—atherosclerosis	2.46e-06	2.47e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOA1—atherosclerosis	2.46e-06	2.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—atherosclerosis	2.45e-06	2.46e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AGT—atherosclerosis	2.44e-06	2.45e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTHFR—atherosclerosis	2.43e-06	2.44e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOE—atherosclerosis	2.43e-06	2.44e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LEP—atherosclerosis	2.43e-06	2.44e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	2.42e-06	2.43e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK8—atherosclerosis	2.42e-06	2.43e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CG—atherosclerosis	2.41e-06	2.43e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—atherosclerosis	2.41e-06	2.42e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CAV1—atherosclerosis	2.4e-06	2.42e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOA1—atherosclerosis	2.4e-06	2.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—atherosclerosis	2.39e-06	2.4e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOE—atherosclerosis	2.39e-06	2.4e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOB—atherosclerosis	2.37e-06	2.38e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PDGFB—atherosclerosis	2.37e-06	2.38e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CAV1—atherosclerosis	2.37e-06	2.38e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOA1—atherosclerosis	2.36e-06	2.37e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—atherosclerosis	2.35e-06	2.36e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PPARG—atherosclerosis	2.34e-06	2.35e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—atherosclerosis	2.34e-06	2.35e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HMOX1—atherosclerosis	2.32e-06	2.33e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ESR1—atherosclerosis	2.32e-06	2.33e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTM1—atherosclerosis	2.3e-06	2.32e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—INS—atherosclerosis	2.29e-06	2.3e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—F2—atherosclerosis	2.29e-06	2.3e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—INS—atherosclerosis	2.29e-06	2.3e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOE—atherosclerosis	2.26e-06	2.27e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—LPL—atherosclerosis	2.26e-06	2.27e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL2—atherosclerosis	2.25e-06	2.26e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CG—atherosclerosis	2.24e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CAV1—atherosclerosis	2.24e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MAPK3—atherosclerosis	2.24e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOA1—atherosclerosis	2.24e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NFKB1—atherosclerosis	2.23e-06	2.24e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOB—atherosclerosis	2.22e-06	2.24e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—atherosclerosis	2.22e-06	2.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—STAT3—atherosclerosis	2.21e-06	2.22e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1—atherosclerosis	2.21e-06	2.22e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GPX1—atherosclerosis	2.21e-06	2.22e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK8—atherosclerosis	2.19e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CG—atherosclerosis	2.19e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPARG—atherosclerosis	2.16e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTM1—atherosclerosis	2.16e-06	2.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CG—atherosclerosis	2.15e-06	2.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CD36—atherosclerosis	2.15e-06	2.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—atherosclerosis	2.13e-06	2.14e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—LPL—atherosclerosis	2.12e-06	2.13e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—INS—atherosclerosis	2.12e-06	2.13e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK3—atherosclerosis	2.11e-06	2.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS2—atherosclerosis	2.11e-06	2.12e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—atherosclerosis	2.1e-06	2.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SERPINE1—atherosclerosis	2.1e-06	2.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPARG—atherosclerosis	2.08e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—INS—atherosclerosis	2.07e-06	2.08e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GPX1—atherosclerosis	2.07e-06	2.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—STAT3—atherosclerosis	2.04e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—INS—atherosclerosis	2.04e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL2—atherosclerosis	2.04e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MTHFR—atherosclerosis	2.04e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CD36—atherosclerosis	2.02e-06	2.03e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—atherosclerosis	2.01e-06	2.02e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—STAT3—atherosclerosis	2.01e-06	2.02e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1—atherosclerosis	2e-06	2.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—atherosclerosis	2e-06	2.01e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARA—atherosclerosis	2e-06	2.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAPK3—atherosclerosis	1.95e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—atherosclerosis	1.95e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AGT—atherosclerosis	1.93e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—INS—atherosclerosis	1.93e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK3—atherosclerosis	1.92e-06	1.93e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MTHFR—atherosclerosis	1.91e-06	1.92e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SERPINE1—atherosclerosis	1.9e-06	1.91e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—atherosclerosis	1.9e-06	1.91e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOE—atherosclerosis	1.9e-06	1.9e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—atherosclerosis	1.89e-06	1.9e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAV1—atherosclerosis	1.88e-06	1.89e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARA—atherosclerosis	1.88e-06	1.89e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOA1—atherosclerosis	1.87e-06	1.88e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—atherosclerosis	1.87e-06	1.88e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—atherosclerosis	1.86e-06	1.87e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—atherosclerosis	1.84e-06	1.85e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—atherosclerosis	1.82e-06	1.83e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AGT—atherosclerosis	1.82e-06	1.83e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—atherosclerosis	1.79e-06	1.8e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOE—atherosclerosis	1.78e-06	1.79e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL8—atherosclerosis	1.78e-06	1.79e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SERPINE1—atherosclerosis	1.78e-06	1.78e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAV1—atherosclerosis	1.76e-06	1.77e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOA1—atherosclerosis	1.76e-06	1.77e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.71e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—atherosclerosis	1.7e-06	1.71e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—atherosclerosis	1.7e-06	1.7e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARG—atherosclerosis	1.65e-06	1.66e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—atherosclerosis	1.64e-06	1.64e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—INS—atherosclerosis	1.62e-06	1.63e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL8—atherosclerosis	1.61e-06	1.62e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—atherosclerosis	1.61e-06	1.62e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	1.61e-06	1.61e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NFKB1—atherosclerosis	1.59e-06	1.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK8—atherosclerosis	1.56e-06	1.57e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARG—atherosclerosis	1.55e-06	1.56e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—atherosclerosis	1.54e-06	1.55e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—INS—atherosclerosis	1.52e-06	1.53e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—atherosclerosis	1.51e-06	1.52e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—atherosclerosis	1.48e-06	1.49e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—atherosclerosis	1.46e-06	1.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—atherosclerosis	1.44e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NFKB1—atherosclerosis	1.44e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STAT3—atherosclerosis	1.43e-06	1.44e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—atherosclerosis	1.43e-06	1.43e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—atherosclerosis	1.43e-06	1.43e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—atherosclerosis	1.42e-06	1.43e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK8—atherosclerosis	1.42e-06	1.43e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—atherosclerosis	1.4e-06	1.41e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—atherosclerosis	1.39e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK3—atherosclerosis	1.37e-06	1.37e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—atherosclerosis	1.33e-06	1.34e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—atherosclerosis	1.33e-06	1.33e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—atherosclerosis	1.32e-06	1.32e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—atherosclerosis	1.31e-06	1.32e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT3—atherosclerosis	1.3e-06	1.3e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—atherosclerosis	1.29e-06	1.3e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK3—atherosclerosis	1.24e-06	1.24e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—atherosclerosis	1.22e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT3—atherosclerosis	1.21e-06	1.22e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—atherosclerosis	1.2e-06	1.21e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—atherosclerosis	1.17e-06	1.18e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAPK3—atherosclerosis	1.16e-06	1.16e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—atherosclerosis	1.12e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—atherosclerosis	9.99e-07	1e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—atherosclerosis	9.24e-07	9.29e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—atherosclerosis	9.21e-07	9.26e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—atherosclerosis	9.06e-07	9.1e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—atherosclerosis	8.56e-07	8.6e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—atherosclerosis	8.45e-07	8.49e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—atherosclerosis	8.36e-07	8.4e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—atherosclerosis	8.22e-07	8.26e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—atherosclerosis	7.79e-07	7.83e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—atherosclerosis	6.53e-07	6.56e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—atherosclerosis	6.13e-07	6.16e-06	CbGpPWpGaD
